Rapid epinephrine absorption with a time to reach the 100 pg/mL threshold concentration in 9 minutes after dosing
Sustained pharmacokinetics (PK) with plasma epinephrine concentration remaining above 100 pg/mL for 2 hours post-dose, ensuring a durable treatment effect
Safe and well tolerated, with only mild, transient, and self-resolving adverse events (AEs) reported
Oct. 07, 2024 -- Insignis Therapeutics, a leader in innovative allergy and anaphylaxis treatments, is excited to announce positiv